Abstract
Despite great technical improvements in radiotherapy and surgery, survival for patients with squamous cell carcinoma of the head and neck (SCCHN) has still not improved significantly over the last decades. Management of SCCHN has mainly been based on the TNM staging and site over this time period, even though we know that there are individual differences independent of the TNM status. Individual patients with small tumors might have a poor outcome, and patients with large tumors may end up with a favorable prognosis, despite their respective TNM classification. Recent molecular studies indicate that underlying genetic abnormalities may reflect such individual differences independently of TNM status. Individualization of treatment based on such biological properties of the tumors might result in less over as well as under treatment. However, the optimal panel of biomarkers to be used for the individualization of treatment is yet to be defined. A variety of laboratory techniques have been used in studies that investigate the individual biological features, spanning from methods that screen the genome for chromosomal and genetic abnormalities, e.g., cytogenetics, CGH, SKY and cDNA micro array, to detailed studies of specific aberrations. The purpose of this review of the literature is to summarize what has been studied so far by methods for genetic screening and to relate these results to the prediction of the clinical outcome. We conclude that it is time to focus future prospective studies on how treatment can be individualized based on biomarkers in combination with the macroscopic features of SCCHN.
Similar content being viewed by others
References
Quon H, Liu F, Cummings B (2001) Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck 23:147–159
van’t Veer L, Dai H, van de Vijer M (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874
Singh D, Febbo P, Ross K, Jackson D, Manola J, Ladd C, et al (2002) Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1:203–209
Kallioniemi A, Kallioniemi O, Sudar D, Rutovitz D, Gray J, Waldman F et al (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818–821
Liyanage M, Coleman A, du Manoir S, Veldman T, McCormack S, Dickson R, et al (1996) Multicolour spectral karyotyping of mouse chromosomes. Nat Genet 14:312–315
Eisen M, Brown P (1991) DNA arrays for analysis of gene expression. Methods Enzymol 303:170–205
Gollin S (2001) Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 23:238–253
Gebhart E (2004) Comparative genomic hybridization (CGH): 10 years of substantial progress in human solid tumor molecular cytogenetics. Cytogenet Genome Res 104:352–358
Brzoska P, Levin N, Fu K, Kaplan M, Singer M, Gray J, et al (1995) Frequent novel DNA copy number increase in squamous cell head and neck tumors. Cancer Res 15:3055–3059
Speicher M, Howe C, Crotty P, du Manoir S, Costa J, Ward D (1995) Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 55:1010–1013
Bockmuhl U, Petersen S, Schmidt S, Wolf G, Jahnke V, Dietel M, et al (1997) Patterns of chromosomal imbalances in metastasizing and nonmetastasizing head and neck cancer. Cancer Res 57:5313–5316
Bockmuhl U, Schluns K, Schmidt S, Matthias S, Petersen I (2002) Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma. Genes Chromosomes Cancer 33:29–35
Patmore H, James N, Cawkwell L, MacDonald A, Stafford N, Greenman J (2004) Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation? Br J Cancer 90:1976–1982
Bockmuhl U, You X, Pacyna-Gengelbach M, Arps H, Draf W, Petersen I (2004) CGH pattern of esthesioneuroblastoma and their metastases. Brain Pathol 14:158–163
Riazimand S, Brieger J, Jacob R, Welkoborsky H, Mann W (2002) Analysis of cytogenetic aberrations in esthesioneuroblastomas by comparative genomic hybridization. Cancer Genet Cytogenet 136:53–57
Bockmuhl U, Schwendel A, Dietel M, Petersen I (1996) Distinct patterns of chromosomal alterations in high and low grade head and neck squamous cell carcinomas. Cancer Res 56:5325–5329
Schwerer M, Hemmer J, Kraft K, Maier H, Moller P, Barth T (2003) Endoreduplication in conjunction with tumor progression in an aneuploid laryngeal squamous cell carcinoma. Virchows Arch 443:98–103
Huang Q, Yu G, McCormick S, Mo J, Datta B, Mahimkar M, et al (2002) Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 34:224–233
Golub T, Slonim D, Tamayo P, Huard C, Gaasenbeek M, Mesirov J, et al (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286:531–537
Alizadeh A, Eisen M, Davis R, Ma C, Lossos I, Rosenwald A, et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503–511
Cromer A, Carles A, Millon R, Ganguli G, Chalmel F, Lemaire F, et al (2003) Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarra analysis. Oncogene 23:2484–2498
Lemaire F, Millon R, Young J, Cromer A, Wasylyk C, Schultz I, et al (2003) Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Br J Cancer 89:1940–1949
Villaret D, Wang T, Dillon D, Xu J, Sivam D, Cheever M, et al (2000) Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 110:374–381
Sok J, Kuriakose M, Mahajan V, Pearlman A, DeLacure M, Chen F (2003) Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis. Arch Otolaryngol Head Neck Surg 129:760–770
Alevizos I, Mahadevappa M, Zhang X, Ohyama H, Kohno Y, Posner M, et al (2001) Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 27:6196–6204
Leethanakul C, Knezevic V, Patel V, Amornphimoltham P, Gillespie J, Shillitoe E, et al (2003) Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis. Oral Oncol 39:248–258
Leethanakul C, Patel V, Gillespie J, Shillitoe E, Kellman R, Ensley J, et al (2000) Gene expression profiles in squamous cell carcinomas of the oral cavity: use of laser capture microdissection for the construction and analysis of stage-specific cDNA libraries. Oral Oncol 36:474–483
Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley J, Koontongkaew S, et al (2000) Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 19:3220–3224
Al Moustafa A, Alaoui-Jamali M, Batist G, Hernandez-Perez M, Serruya C, Alpert L, et al (2002) Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 21:2634–2640
El-Naggar A, Kim H, Clayman G, Coombes M, Le B, Lai S, et al (2002) Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classification. Oncogene 21:8206–8219
Mendez E, Cheng C, Farwell D, Ricks S, Agoff S, Futran N, et al (2002) Transcriptional expression profiles of oral squamous cell carcinomas. Cancer 95:1482–1494
Schmalbach C, Chepeha D, Giordano T, Rubin M, Teknos T, Bradford C, et al (2004) Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130:295–302
Nagata M, Fujita H, Ida H, Hoshina H, Inoue T, Seki Y, et al (2003) Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer 106:683–689
Ito H, Hatori M, Kinugasa Y, Irie T, Tachikawa T, Nagumo M (2003) Comparison of the expression profile of metastasis-associated genes between primary and circulating cancer cells in oral squamous cell carcinoma. Anticancer Res 23:1425–1431
Cromer A, Carles A, Millon R, Ganguli G, Chalmel F, Lemaire F, et al (2004) Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 23:2484–2498
Hu Y, Lam K, Law S, Wong J, Srivastava G (2001) Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC. Clin Cancer Res 7:3519–3525
Akervall J, Jin Y, Wennerberg J, Zatterstrom U, Kjellén E, Mertens F, et al (1995) Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer 76:853–859
Zaharieva B, Simon R, Diener P, Ackermann D, Maurer R, Alund G, et al (2003) High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol 201:603–608
Bockmuhl U, Schluns K, Kuchler I, Petersen S, Petersen I (2000) Genetic imbalances with impact on survival in Head and Neck cancer patients. Am J Pathol 157:369–375
Wreesmann V, Shi W, Thaler H, Poluri A, Kraus D, Pfister D, et al (2004) Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J Clin Oncol 22:3965–3972
Pearlstein R, Benninger M, Carey T (1998) Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck. Genes Chromosomes Cancer 21:333–339
Wreesmann V, Sieczka E, Socci N, Hezel M, Belbin T, Childs G, et al (2004) Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. Cancer Res 64:3780–3789
Yoo G, Piechocki M, Ensley J, Nguyen T, Oliver J, Meng H, et al (2002) Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot. Clin Cancer Res 8:3910–3921
Akervall J, Guo X, Qian C-N, Schoumans J, Cole A, Leeser B, et al (2004) Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients. Clin Cancer Res 10:8204–8213
Kihara C, Tsunoda T, Tanaka T, Yamana H, Furukawa Y, Ono K, et al (2001) Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res 61:6474–6479
Belbin T, Singh B, Barber I, Socci N, Wenig B, Smith R, et al (2002) Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 62:1184–1190
Ishibashi Y, Hanyu N, Nakada K, Suzuki Y, Yamamoto T, Yanaga K, et al (2003) Profiling gene expression ratios of paired cancerous and normal tissue predicts relapse of esophageal squamous cell carcinoma. Cancer Res 63:5159–5164
Genden E, Ferlito A, Bradley P, Rinaldo A, Scully C (2003) Neck disease and distant metastases. Oral Oncol 39:207–212
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Akervall, J. Genomic screening of head and neck cancer and its implications for therapy planning. Eur Arch Otorhinolaryngol 263, 297–304 (2006). https://doi.org/10.1007/s00405-006-1039-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-006-1039-1